NEW ANTIVIRAL DRUG TRIAZID. RESULTS OF FIRST PHASE OF CLINICAL TRIAL

QR Code

NEW ANTIVIRAL DRUG TRIAZID. RESULTS OF FIRST PHASE OF CLINICAL TRIAL

The paper contains а results of the study of the pharmacokinetics, tolerability and safety of a new influenza drug Triazide in several dose regimens conducted on healthy volunteers. The convenient method for the determining the Triazide in blood plasma and urine by the HPLC have been proposed for th...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. G. Deyeva, Yu. I. Shevchik, A. A. Shaldghan, K. A. Zagorodnikova, A. A. Tumashov, A. V. Baklykov, S. K. Kotovskaya, O. N. Chupahin, V. N. Charushin, V. L. Rusinov, D. S. Kopchuk
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	triazide influenza clinical research safety pharmacokinetics
Online Access:	https://www.pharmjournal.ru/jour/article/view/623
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SIMULTANEOUS DETERMINATION OF AMINOTRIAZOLE AND TRIAZOLOPYRIMIDINONE - SUBSTRATE AND INTERMEDIATE IN THE SYNTHESIS OF «TRIAZIDE» BY HPLC
by: A. V. Baklykov, et al.
Published: (2019-01-01)

METHOD OF SIMANTENOUS DETERMINATION OF AMINOTRIAZOLE, TRIAZOLOPYRIMIDINONE AND NITROTRIAZOLOPIRIMIDINONE - SUBSTRATE AND SEMI-PRODUCTS OF SYNTHESIS OF DRUG «TRIAZID» BY HPLC METHOD
by: A. V. Baklykov, et al.
Published: (2019-01-01)

METHOD OF DETERMINATION OF 5-METHYL-6-NITRO-7-OXO-1,2,4-TRIAZOLO[1,5-<i>a</i>]PIRIMIDINIDE <i>l-</i>ARGININY - THE ACTIVE COMPONENT OF DRUG «TRIAZID» BY HPLC METHOD
by: A. V. Baklykov, et al.
Published: (2019-01-01)

Triazaverin Prophylactic Efficacy Against Influenza Virus A (H5N1)
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Antiviral Activity of Kagocel® on the Model of Experimental Lethal Influenza Infection
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs
by: E. A. Prokopyeva, et al.
Published: (2019-12-01)

Study of the Antiviral Activity of Adamantane-Containing Chemical Compounds
by: I. I. LYUBIMOV, et al.
Published: (2022-11-01)

Antiviral Activity of Ingavirin® in Experimental Lethal Influenza Due to Influenza Virus B in Albino Mice
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2024-03-01)

Study of the Antiviral Activity of Drugs and Their Combination Against the Influenza A Virus
by: E. N. Vetrova, et al.
Published: (2025-02-01)

Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2024-03-01)

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial
by: T. N. Komarov, et al.
Published: (2024-03-01)

Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2023-05-01)

Pharmacokinetic Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2022-12-01)

Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)
by: T. I. Smolyanova, et al.
Published: (2022-05-01)

Therapeutic Efficacy of Triazavirin, a Novel Russian Chemotherapeutic, Against Influenza Virus A (H5N1)
by: S. A. Loginova, et al.
Published: (2020-05-01)

Antiviral therapy of acute respiratory viral infection and influenza in children in a hospital
by: E. V. Sharipova, et al.
Published: (2018-12-01)

THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE
by: A. V. Kryukov, et al.
Published: (2016-06-01)

The antiviral activity of cerium and lanthanum nanooxides modified with silver
by: M. M. Zahornyi, et al.
Published: (2023-05-01)

Evaluation of the Antiviral Activity of Drugs from the Group of Polymer Electrolyte Derivatives against a Wide Range of Viruses
by: D. N. Razgulyaeva, et al.
Published: (2024-01-01)

A Double-blind Randomized Comparative Phase I Study to Assess Biosimilarity and Immunogenicity of "Trastuzumab" (LLC "Mabscale", Russia) and Herceptin® (F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Volunteers
by: M. A. Kolganova, et al.
Published: (2023-09-01)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
by: I. V. Losev, et al.
Published: (2017-08-01)

Development of DNA-Biochip for Identification of Influenza A Virus Subtypes
by: A. N. Shikov, et al.
Published: (2012-04-01)

Experimental Medications Made with <i>Сetraria islandica</i> Showing Antiviral Activity against Influenza A Virus
by: E. V. Makarevich, et al.
Published: (2024-01-01)

Investigation of Antiviral Activity of Adamantan Boron Derivaties on Pandemic Influenza Virus Models
by: S. G. Markushin, et al.
Published: (2020-05-01)

Comparative Analysis of the Antiviral Activity of Various Drugs Based on 6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide (Favipiravir) Against COVID-19
by: S. Ya. Loginova, et al.
Published: (2024-06-01)

Safety, reactogenicity, and immunogenicity of a viral vector vaccine against influenza A: Phase I open clinical trial
by: M. M. Shmarov, et al.
Published: (2025-04-01)

Study of Ingavirin® Antiviral Activity against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro and in vivo
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Effect of antiviral siRNAs on the production of cytokines in vitro
by: A. V. Pak, et al.
Published: (2022-11-01)

Investigation of Triazavirin Antiviral Activity Against Tick-Borne Encephalitis Pathogen in Cell Culture
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Pharmacokinetic and Bioequivalence Study of Telzap AM<sup>®</sup> (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis<sup>®</sup> (Telmisartan) and Norvask<sup>®</sup> (Amlodipine) in Healthy Subjects
by: V. Kubesh, et al.
Published: (2020-11-01)

Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice
by: A. P. Budko, et al.
Published: (2019-01-01)

Investigation of Ingavirin® Antiviral Activity Against Season Influenza Virus A/H1N1 in MDCK Cell Culture
by: G. A. Galegov, et al.
Published: (2020-05-01)

Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?
by: Darius Babusis, et al.
Published: (2025-06-01)

METHODS OF STABILIZATION OF DRUG SUBSTANCES AND THEIR METABOLITES IN BIOLOGICAL FLUIDS DURING BIOANALYTICAL STUDY (REVIEW)
by: I. I. Yaichkov, et al.
Published: (2019-01-01)

Comparative clinical and economic evaluation of two alternative antiviral therapy regimens for influenza patients
by: I. I. Tokin, et al.
Published: (2018-07-01)

The Antiviral Activity Study of Complex Drug with Aminocapronic Acid for Prevention of Influenza and ARVI
by: A. S. Karpova, et al.
Published: (2019-05-01)

Comparative Bioequivalence Studies of doxysam and doxycycline (Pfizer) by reversed phase HPLC.
by: Baghdad Science Journal
Published: (2010-03-01)

Pharmacokinetic and bioequivalence study of Telzap® in comparison with Mikardis® in healthy subjects after single administrationl
by: A. L. Khokhlov, et al.
Published: (2023-01-01)

Liposomes – metabolically active drug transport systems: visualization and pharmacokinetic. Part 2 (review)
by: O. N. Pozharitskaya, et al.
Published: (2024-11-01)